Anchyra Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Anchyra Partners's AMGN Position: Q2 2026 in Review
Anchyra Partners increased its Amgen (AMGN) stake by 3.5% in Q2 2026, buying an estimated $35.6K and bringing the position to 3,094 shares worth $1.12M. The position accounts for 0.27% of the portfolio, ranked #73.
Anchyra Partners first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 2,083 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Anchyra Partners held 3,094 shares of Amgen worth $1.12M as of Q2 2026.
- Anchyra Partners bought 104 Amgen shares in Q2 2026, an estimated $35.6K.
- Amgen made up 0.27% of Anchyra Partners's portfolio in Q2 2026, its #73 holding.
- Anchyra Partners first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
- 2,083 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.